1. Home
  2. BZH vs AVBP Comparison

BZH vs AVBP Comparison

Compare BZH & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • AVBP
  • Stock Information
  • Founded
  • BZH 1985
  • AVBP 2021
  • Country
  • BZH United States
  • AVBP United States
  • Employees
  • BZH N/A
  • AVBP N/A
  • Industry
  • BZH Homebuilding
  • AVBP
  • Sector
  • BZH Consumer Discretionary
  • AVBP
  • Exchange
  • BZH Nasdaq
  • AVBP NYSE
  • Market Cap
  • BZH 666.1M
  • AVBP 862.8M
  • IPO Year
  • BZH 1994
  • AVBP 2024
  • Fundamental
  • Price
  • BZH $23.09
  • AVBP $21.99
  • Analyst Decision
  • BZH Strong Buy
  • AVBP Strong Buy
  • Analyst Count
  • BZH 3
  • AVBP 8
  • Target Price
  • BZH $33.00
  • AVBP $39.00
  • AVG Volume (30 Days)
  • BZH 332.4K
  • AVBP 484.5K
  • Earning Date
  • BZH 07-31-2025
  • AVBP 08-13-2025
  • Dividend Yield
  • BZH N/A
  • AVBP N/A
  • EPS Growth
  • BZH N/A
  • AVBP N/A
  • EPS
  • BZH 3.10
  • AVBP N/A
  • Revenue
  • BZH $2,436,131,000.00
  • AVBP N/A
  • Revenue This Year
  • BZH N/A
  • AVBP $66.25
  • Revenue Next Year
  • BZH $14.27
  • AVBP N/A
  • P/E Ratio
  • BZH $7.22
  • AVBP N/A
  • Revenue Growth
  • BZH 13.50
  • AVBP N/A
  • 52 Week Low
  • BZH $17.37
  • AVBP $15.47
  • 52 Week High
  • BZH $38.22
  • AVBP $36.37
  • Technical
  • Relative Strength Index (RSI)
  • BZH 57.43
  • AVBP 50.46
  • Support Level
  • BZH $21.73
  • AVBP $22.04
  • Resistance Level
  • BZH $22.84
  • AVBP $25.73
  • Average True Range (ATR)
  • BZH 0.75
  • AVBP 1.40
  • MACD
  • BZH 0.02
  • AVBP -0.25
  • Stochastic Oscillator
  • BZH 61.61
  • AVBP 20.48

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

Share on Social Networks: